Oncology Medical News about Prostate-specific antigen screening

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prostate-specific antigen screening of workers under the age of 40 in Japan
Cancer Epidemiology, 10/22/09

Kawada T et al. – One–sixth of male workers attending the health check–up program were under 40 years of age. According to the criteria of the Japanese Urological Association, this examination program included younger subjects who were not candidates for PSA screening.

<< Previous
Pathological Stage T2 Subgroups to Predict Biochemical Recurrence...

Next >>
Differing Perceptions of Quality of Life in Patients With...

Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras
The Journal of Urology, 10/21/09 Relevance Score: 81%

Prostate Specific Antigen Best Practice Statement: 2009 Update
The Journal of Urology, 11/02/09 Relevance Score: 80%

Public Survey and Survival Data Do Not Support Recommendations to Discontinue Prostate-specific Antigen Screening in Men at Age 75
Urology, 10/12/09 Relevance Score: 80%

Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09 Relevance Score: 80%

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
British Journal of Cancer, 11/13/09 Relevance Score: 79%